_O.webp)
East African India Overseas Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.47 M
as on 16-11-2024
- Company Age 40 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 6540.00%
(FY 2023)
- Ebitda 72635.80%
(FY 2023)
- Net Worth 132.21%
(FY 2023)
- Total Assets 545.12%
(FY 2023)
About East African India Overseas
The Corporate was formerly known as Volpo Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.47 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Jain and Saurabh Jain serve as directors at the Company.
- CIN/LLPIN
U74899DL1984PTC017519
- Company No.
017519
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does East African India Overseas Private Limited offer?
East African India Overseas Private Limited offers a wide range of products and services, including Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at East African India Overseas?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Jain  | Director | 01-Mar-2017 | Current |
| Ram Jain | Additional Director | 10-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of East African India Overseas.
East African India Overseas Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 6540% increase in profit. The company's net worth Soared by an impressive increase of 132.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of East African India Overseas?
In 2023, East African India Overseas had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Odon Prime Pharma Private LimitedActive 7 months 12 daysRam Jain and Saurabh Jain are mutual person
- Odon Lifesciences Private LimitedActive 3 years 2 months
Ram Jain and Saurabh Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at East African India Overseas?
Unlock and access historical data on people associated with East African India Overseas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of East African India Overseas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped East African India Overseas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
